Save information for later
Sign Up

Learn About Microscopic Polyangiitis

What is the definition of Microscopic Polyangiitis?
Microscopic polyangiitis (MPA) is a disorder that causes blood vessel inflammation (vasculitis), which can lead to organ damage. The kidneys, lungs, nerves, skin, and joints are the most commonly affected areas of the body. MPA is diagnosed in people of all ages, all ethnicities, and both genders. The cause of this disorder is unknown.
What are the alternative names for Microscopic Polyangiitis?
  • Microscopic polyangiitis
Who are the top Microscopic Polyangiitis Local Doctors?
Elite in Microscopic Polyangiitis
Rheumatology
Elite in Microscopic Polyangiitis
Rheumatology

University Of Penn-Medical Group

3737 Market St, Fl 8, 
Philadelphia, PA 
Languages Spoken:
English
Offers Telehealth

Peter Merkel is a Rheumatologist in Philadelphia, Pennsylvania. Dr. Merkel and is rated as an Elite provider by MediFind in the treatment of Microscopic Polyangiitis. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy.

Elite in Microscopic Polyangiitis
Rheumatology
Elite in Microscopic Polyangiitis
Rheumatology
150 S Huntington Ave, 
Boston, MA 
Languages Spoken:
English

Paul Monach is a Rheumatologist in Boston, Massachusetts. Dr. Monach and is rated as an Elite provider by MediFind in the treatment of Microscopic Polyangiitis. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Takayasu Arteritis, and Microscopic Polyangiitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Microscopic Polyangiitis
Elite in Microscopic Polyangiitis
Paris, FR 

Xavier Puechal practices in Paris, France. Puechal and is rated as an Elite expert by MediFind in the treatment of Microscopic Polyangiitis. His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Necrotizing Vasculitis, Kidney Transplant, and Endoscopy.

What are the latest Microscopic Polyangiitis Clinical Trials?
A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Subjects With Severe Relapsed or Refractory Autoimmune Diseases (GLEAM)

Summary: SC291-102 is a Phase 1 study to evaluate SC291 safety and tolerability, preliminary clinical response, cellular kinetics and exploratory assessments for subjects with severe autoimmune diseases.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Summary: Naltrexone is an FDA approved drug (for alcoholism) that has found widespread use off-label to treat pain and improve quality of life at much lower doses than are used for the approved indication. There are a few scientific studies in three conditions (fibromyalgia, Crohn's disease, and multiple sclerosis) that suggest that this drug has benefit and is safe. However, considering the extent of use ...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center